Prevalence of multiple sclerosis in Denmark 1950

Abstract

Multiple sclerosis is an inflammatory disease of the central nervous system of unknown aetiology. Its prevalence varies by ethnicity and place: persons of northern European descent are at increased risk while persons living at lower latitudes appear to be protected against the disease.

The Danish Multiple Sclerosis Registry is a national registry established in 1956 after a population-based survey which receives information from numerous sources. It is considered to be more than 90% complete, with a validity of 94%. Using data from the Registry, we calculated prevalences per 100,000 inhabitants.

The standardized prevalence of multiple sclerosis increased from 58.8 (95% confidence interval: 54.9—62.7) in 1950 to 154.5 per 100,000 (95% confidence interval: 148.8—160.2) in 2005, and the female to male ratio increased from 1.31 in 1950 to 2.02 in 2005. The increase in prevalence is due to both increased survival of multiple sclerosis patients and an increased incidence rate.

The rise in prevalence in the past 50 years is probably due more to environmental factors than to genetic changes in the Danish population. Among women, environmental changes could include older age at first birth, use of oral contraceptives, or changes in sun behaviour and/or vitamin D status.

Keywords

multiple sclerosis registry Denmark sex age prevalence

Get full access to this article

View all access options for this article.

References

Sobocki P. , Pugliatti M. , Lauer K. , Kobelt G. Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study. Mult Scler 2007; 13: 1054-1064.

Kobelt G. , Pugliatti M. Cost of multiple sclerosis in Europe. Eur J Neurol 2005; 12: 63-67.

Koch-Henriksen N. , Rasmussen S. , Stenager E. , Madsen M. The Danish Multiple Sclerosis Registry. History, data collection and validity. Dan Med Bull 2001; 48: 91-94.

Allison RS , Millar JH Prevalence of disseminated sclerosis in Northern Ireland. Ulster Med J 1954; 23: 1-27.

Poser CM , Paty DW , Scheinberg L. , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.

Koch-Henriksen N. , Hyllested K. Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry. Acta Neurol Scand 1988; 78: 369-380.

Bronnum-Hansen H. , Stenager E. , Hansen T. , Koch-Henriksen H. Survival and mortality rates among Danes with MS. Int MS J 2006; 13: 66-71.

Bronnum-Hansen H. , Koch-Henriksen N. , Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844-850.

Koch-Henriksen N. , Stenager E. , Brønnum-Hansen H. , Flachs EM Increasing incidence of multiple sclerosis in Danish women (abstract). 22nd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis. September 27-30, 2006. Madrid, Spain.

10.

Etemadifar M. , Janghorbani M. , Shaygannejad V. , Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27: 39-44.

11.

Pekmezovic T. , Jarebinski M. , Drulovic J. , Stojsavljevic N. , Levic Z. Prevalence of multiple sclerosis in Belgrade, Yugoslavia. Acta Neurol Scand 2001; 104: 353-357.

12.

Klupka-Saric I. , Ristic S. , Sepcic J. , et al. Epidemiology of multiple sclerosis in western Herzegovina. Clin Neurol Neurosurg 2007; 109: 779-783.

13.

Orton SM , Ramagopalan SV , Brocklebank DM , et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 2010; 81: 31-36.

14.

Celius EG , Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001; 8: 463-469.

15.

Smestad C. , Sandvik L. , Holmoy T. , Harbo H. , Celius E. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008; 255: 49-55.

16.

Sarasoja T. , Wikstrom J. , Paltamaa J. , Hakama M. , Sumelahti ML Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 2004; 110: 331-336.

17.

Peterlin B. , Ristic S. , Sepcic J. , et al. Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia. J Neurol Sci 2006; 247: 169-172.

18.

Materljan E. , Sepcic J. Epidemiology of multiple sclerosis in Croatia . Clin Neurol Neurosurg 2002; 104: 192-198.

19.

Orton SM , Herrera BM , Yee IM , et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study . Lancet Neurol 2006; 5: 932-936.

20.

Wallin MT , Page WF , Kurtzke JF Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004; 55: 65-71.

21.

Coo H. , Aronson KJ A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 2004; 23: 1-12.

22.

Carnevale V. , Modoni S. , Pileri M. , et al. Longitudinal Evaluation of Vitamin D Status in Healthy Subjects from Southern Italy: Seasonal and Gender Differences . Osteoporos Int 2001; 12: 1026-1030.

23.

Looker AC , Dawson-Hughes B. , Calvo MS , Gunter EW , Sahyoun NR Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30: 771-777.

Prevalence of multiple sclerosis in Denmark 1950—2005

Abstract

Keywords

Get full access to this article

References